News & Updates

Novel targeted therapy shows better response than chemo in BRAF V600-mutant paediatric LGG

05 Jul 2022 by

The combination of two targeted therapies, dabrafenib and trametinib, significantly improves the overall response rate (ORR) in paediatric patients with low-grade glioma (LGG) with BRAF V600 mutations compared with the combination of standard chemotherapy drugs, according to a study presented at ASCO 2022.

Novel targeted therapy shows better response than chemo in BRAF V600-mutant paediatric LGG

05 Jul 2022

Physiotherapy improves neuropathic pain biomarker profile

04 Jul 2022

Physiotherapeutic interventions, like exercise therapy and electro-acupuncture, appear to be effective at reducing the expression of neuropathic pain biomarkers, reveals a new systematic review.

Physiotherapy improves neuropathic pain biomarker profile

04 Jul 2022

Second-line antiseizure drug helps with toxin-related seizure in status epilepticus patients

02 Jul 2022

Some patients with benzodiazepine-refractory status epilepticus experience a toxin-related seizure, which can be successfully treated with a single dose of second-line antiseizure medication, according to a post hoc analysis of the Established Status Epilepticus Treatment Trial (ESETT).

Second-line antiseizure drug helps with toxin-related seizure in status epilepticus patients

02 Jul 2022

Routine cerebral magnetic resonance imaging catches low-grade pathologies in preemies

02 Jul 2022

The routine implementation of cerebral magnetic resonance imaging (cMRI) commonly detects low-grade abnormalities in extremely premature infants, such as low-grade intraventricular haemorrhage (IVH), white matter disease (WMD), and cerebellar injury (CBI), a new study has found.

Routine cerebral magnetic resonance imaging catches low-grade pathologies in preemies

02 Jul 2022

Ultra-high-dose methylcobalamin may reduce clinical progression in early-stage ALS

01 Jul 2022 by

Ultra-high-dose methylcobalamin (MeCbl) slowed functional decline in individuals with early-stage amyotrophic lateral sclerosis (ALS) with moderate progression, the JETALS* study has shown.

Ultra-high-dose methylcobalamin may reduce clinical progression in early-stage ALS

01 Jul 2022

High leucine tied to worse executive function in kids

30 Jun 2022 by

Executive function (EF) in children appears to be linked to the metabolome, particularly with the amino acid leucine, higher levels of which seem to worsen EF and memory in this population, according to a recent Singapore study.

High leucine tied to worse executive function in kids

30 Jun 2022

Oral contraceptive, hormone replacement therapy pose increased stroke risk

29 Jun 2022

The use of oral contraceptive and hormone replacement therapy may put women at heightened risk of stroke, especially within the first year of use, possibly due to immediate changes in haemostatic balance, according to a study.

Oral contraceptive, hormone replacement therapy pose increased stroke risk

29 Jun 2022

Revacept beneficial to patients with symptomatic ICA stenosis

26 Jun 2022

Patients with symptomatic internal carotid artery (ICA) stenosis may fare well with revacept, a competitive antagonist of glycoprotein VI, as the drug helps reduce the incidence of stroke or death, transient ischaemic attack, and bleeding complications, among others, according to a study.

Revacept beneficial to patients with symptomatic ICA stenosis

26 Jun 2022

Diabetes, fertility treatment, family history up autism risk in infants

26 Jun 2022

A recent Egypt study has identified several maternal and neonatal factors contributing to the risk of autism spectrum disorders (ASD) in infants, including the use of assisted fertility treatments, family medical history, and threatened abortion.

Diabetes, fertility treatment, family history up autism risk in infants

26 Jun 2022

EEG-based neurofeedback improves attention in teens

25 Jun 2022

The use of electroencephalogram-based neurofeedback (EEG-NF) can help combat inattention among adolescents and young adults, though its efficacy for controlling hyperactivity or impulsivity remains unestablished, a recent meta-analysis has found.

EEG-based neurofeedback improves attention in teens

25 Jun 2022

News & Updates

Filter by Specialty:

Specialty:

Novel targeted therapy shows better response than chemo in BRAF V600-mutant paediatric LGG

Novel targeted therapy shows better response than chemo in BRAF V600-mutant paediatric LGG

Physiotherapy improves neuropathic pain biomarker profile

Physiotherapy improves neuropathic pain biomarker profile

Second-line antiseizure drug helps with toxin-related seizure in status epilepticus patients

Second-line antiseizure drug helps with toxin-related seizure in status epilepticus patients

Routine cerebral magnetic resonance imaging catches low-grade pathologies in preemies

Routine cerebral magnetic resonance imaging catches low-grade pathologies in preemies

Ultra-high-dose methylcobalamin may reduce clinical progression in early-stage ALS

Ultra-high-dose methylcobalamin may reduce clinical progression in early-stage ALS

High leucine tied to worse executive function in kids

High leucine tied to worse executive function in kids

Oral contraceptive, hormone replacement therapy pose increased stroke risk

Oral contraceptive, hormone replacement therapy pose increased stroke risk

Revacept beneficial to patients with symptomatic ICA stenosis

Revacept beneficial to patients with symptomatic ICA stenosis

Diabetes, fertility treatment, family history up autism risk in infants

Diabetes, fertility treatment, family history up autism risk in infants

EEG-based neurofeedback improves attention in teens

EEG-based neurofeedback improves attention in teens